Orion Corporation, Orion Pharma: all 101 studies

Page 1 of 2. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With CancerRecruitingNCT07805252Phase 1/2
• A 2-part Phase 1/2 Open-label Trial on ODM-212RecruitingNCT07563738Phase 1/2
• A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid TumoursRecruitingNCT06725758Phase 1/2
• Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label ExtensionTerminatedNCT03948178Phase 3Results posted
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALSCompletedNCT03505021Phase 3Results posted
• Dose-finding Pharmacokinetic Study in Healthy MalesCompletedNCT03055936Phase 1Results posted
• Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy VolunteersCompletedNCT02393950Phase 1Results posted
• Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001CompletedNCT01429064Phase 2Results posted
• Safety and Efficacy of ORM-12741 in Patients With Alzheimer's DiseaseCompletedNCT01324518Phase 2Results posted
• Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerCompletedNCT01317641Phase 1/2Results posted
• Efficacy and Tolerability of Tasipimidine in Sleepless PatientsCompletedNCT06956495Phase 2
• Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear CanalCompletedNCT05811039Not applicable
• Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference ProductCompletedNCT05288075Phase 1
• Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHalerCompletedNCT05246046Phase 1
• Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge TestingCompletedNCT05084222Phase 4
• Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With AsthmaCompletedNCT04869384Phase 4
• Absorption of Indacaterol and Glycopyrronium From Ultibro BreezhalerCompletedNCT04856098Phase 1
• Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®CompletedNCT04850144Phase 1
• Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in NorwayTerminatedNCT04663386
• Blood-Brain Barrier Penetration of Therapeutic Agents in HumanCompletedNCT04571996Phase 1
• Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic PainCompletedNCT04225884Not applicable
• Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHalerCompletedNCT04147572Not applicable
• Effect of Charcoal on Gastrointestinal Absorption of TiotropiumCompletedNCT03945344Phase 1
• Safety and Pharmacokinetics of ODM-209CompletedNCT03878823Phase 1/2
• Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICUCompletedNCT03813277Phase 4
• Efficacy and Safety of Remo-Wax for Removal of Impacted EarwaxCompletedNCT03802903Not applicable
• Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPDCompletedNCT03755544
• Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT03436485Phase 1/2
• Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva HandihalerCompletedNCT03400241Phase 1
• Impact of Changing the Dosing Regimen on the PK Profile of ODM-203CompletedNCT03240445Phase 1
• Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)CompletedNCT03238482Phase 1
• Pharmacokinetic of Levodopa Study in Healthy MalesCompletedNCT03140956Phase 1
• Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedNCT03073057Phase 1
• Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide DiskusCompletedNCT03060044Phase 1
• ODM-207 in Patients With Advance Solid TumoursCompletedNCT03035591Phase 1/2
• Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)CompletedNCT02764125Phase 2
• Pharmacokinetic Study in Healthy VolunteersCompletedNCT02554734Phase 1
• Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral SclerosisCompletedNCT02487407Phase 2
• Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's DiseaseCompletedNCT02471196Phase 2
• Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male VolunteersTerminatedNCT02432664Phase 1
• Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male SubjectsCompletedNCT02418650Phase 1
• Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT02344017Phase 1/2
• Pharmacokinetic Study of Single Doses of ORM-12741CompletedNCT02319057Phase 1
• Pharmacokinetic Study in Healthy MalesCompletedNCT02312232Phase 1
• To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference ProductCompletedNCT02308098Phase 3
• Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)CompletedNCT02303860Phase 1
• Safety and Tolerability of ODM-203 in Subjects With Advanced Solid TumoursCompletedNCT02264418Phase 1
• Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide DiskusCompletedNCT02162485Phase 1
• Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide DiskusCompletedNCT01856621Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy VolunteersCompletedNCT01840423Phase 1
• Safety and Tolerability Study With Single Ascending Doses of ODM-102CompletedNCT01839019Phase 1
• Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate CancerCompletedNCT01784757Phase 1
• Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at HomeTerminatedNCT01783132Not applicable
• Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide DiskusCompletedNCT01766843Phase 1
• Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor FluctuationsCompletedNCT01766258Phase 2
• Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care PatientsTerminatedNCT01707680
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy VolunteersCompletedNCT01688089Phase 1
• Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder InhalersCompletedNCT01668121Phase 1
• Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler ForteCompletedNCT01627158Phase 1
• Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedNCT01593826Phase 1
• Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate CancerCompletedNCT01574846
• Phase I Pharmacokinetic Study (SALBLOCK)CompletedNCT01564199Phase 1
• Efficacy and Safety of Ibuprofen in Patients With Ankle InjuriesCompletedNCT01563289Phase 3
• Efficacy and Safety of Ibuprofen in Patients With Ankle InjuriesCompletedNCT01562717Phase 3
• Pharmacokinetic Pilot Study on Budesonide/FormoterolCompletedNCT01457716Not applicable
• Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)CompletedNCT01424137Not applicable
• Phase I Pharmacokinetic Study (BF-BLOCK)CompletedNCT01423305Phase 1
• Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedNCT01386996Phase 1
• Efficacy of ORM-12741 for Prevention of Raynaud's PhenomenonTerminatedNCT01315899Phase 2
• Comparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensCompletedNCT01296464Phase 2
• Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder InhalersCompletedNCT01181063Phase 1
• Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg TabletsCompletedNCT01083290Phase 1
• Levodopa Concentration Profile With Stalevo 75/125 mgCompletedNCT01070628Phase 1
• Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741CompletedNCT01068028Phase 1
• Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler InhalersCompletedNCT00984906Not applicable
• Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in AsthmaticsCompletedNCT00964535Phase 1/2
• Bioequivalence Study Comparing Two Alprazolam 1 mg TabletsCompletedNCT00878865Phase 1
• Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed ConditionsCompletedNCT00878514Phase 1
• Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder InhalerCompletedNCT00868426Phase 1
• Effect of Moisturising Creams on Skin Moisture in Atopic DermatitisCompletedNCT00846235Phase 4
• Early Phase I Microdosing Study of ORM-14540 and ORM-12741CompletedNCT00831077Early Phase 1
• A PET Study With ORM-12741CompletedNCT00829907Phase 1
• Pharmacokinetic Study of ORM-12741 in Healthy VolunteersCompletedNCT00818740Phase 1
• Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741CompletedNCT00817544Phase 1
• Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741CompletedNCT00792493Phase 1
• Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICUCompletedNCT00747721Phase 1
• Suitability of 11C-ORM-13070 as a PET TracerCompletedNCT00735774Phase 1
• Effects of Oral Levosimendan on Ambulatory Electrocardiographic VariablesCompletedNCT00698763Phase 2
• Pharmacokinetic Study With Repeated Doses of StalevoCompletedNCT00693862Phase 1
• Safety and Tolerability Study With Single Ascending Doses of ORM-12741CompletedNCT00693316Phase 1
• Comparison of PEG Solutions With and Without Electrolytes in the Treatment of ConstipationCompletedNCT00603681Phase 4
• PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride BindingTerminatedNCT00562198Phase 2
• Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)CompletedNCT00481312Phase 3
• Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)CompletedNCT00479661Phase 3
• Study to Evaluate Initiation of Stalevo in Early Wearing-offCompletedNCT00462007Phase 4
• Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.CompletedNCT00247247Phase 4
• Dexmedetomidine for Continuous SedationTerminatedNCT00226785Phase 3
• Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.CompletedNCT00219388Phase 4
• Peroral Levosimendan in Chronic Heart FailureCompletedNCT00130884Phase 2
• Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary BypassCompletedNCT00130871Phase 2

← Orion Corporation, Orion Pharma overview and focus areas